<DOC>
	<DOCNO>NCT00814710</DOCNO>
	<brief_summary>The purpose study assess immunogenicity term antibody response safety/reactogenicity term solicit unsolicited symptom serious adverse event follow primary vaccination Indian infant pneumococcal conjugate vaccine GSK1024850A co-administered diphtheria , tetanus , whole cell pertussis ( DTPw ) -combined vaccine first 4 month life . The study conduct India .</brief_summary>
	<brief_title>Primary Vaccination Study With Pneumococcal Conjugate Vaccine Healthy Children 6 10 Weeks Age</brief_title>
	<detailed_description />
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female subject , include 610 week age time first vaccination . Subjects investigator believe parent ( ) /guardian ( ) comply requirement protocol . Written oral , sign thumbprinted informed consent obtain parent ( ) /guardian ( ) child/ward . Where parent ( ) /guardian ( ) illiterate , consent form countersign witness . Free know suspected health problem ( establish medical history clinical examination enter study ) . Use investigational nonregistered product ( drug vaccine ) study vaccine within 30 day precede first dose study vaccine , plan use study period . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product ( pharmaceutical product device ) . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug since birth . A family history congenital hereditary immunodeficiency . Any confirm suspected immunosuppressive immunodeficient condition base medical history physical examination . Administration immunoglobulins and/or blood product since birth plan administration study period ( exception hepatitis B immunoglobulins birth ) . Previous vaccination diphtheria , tetanus , pertussis , hepatitis B , Haemophilus influenzae type b and/or Streptococcus pneumoniae ( exception hepatitis B vaccination birth least 30 day subject 's first study visit ) . History , intercurrent , diphtheria , tetanus , pertussis , hepatitis B , Streptococcus Haemophilus influenzae type b disease . History allergic disease reaction likely exacerbate component vaccine . History neurological disorder seizure . Major congenital defect serious chronic illness . Acute disease time enrolment . Babies birth weight &lt; 2 kilogram .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pneumococcal disease</keyword>
	<keyword>Pneumococcal vaccine</keyword>
	<keyword>Safety</keyword>
	<keyword>Primary vaccination</keyword>
	<keyword>Immunogenicity</keyword>
</DOC>